Chromatographia

, Volume 15, Issue 7, pp 468–474 | Cite as

Low-level flow counting of liquid chromatography column eluates

  • N. G. L. Harding
  • Y. Farid
  • M. J. Stewart
  • J. Shepherd
  • D. Nicoll
Originals

Summary

The principal parameters which determine the operation of a high-resolution, high-sensitivity radioactive flow monitor are described: a) Sample preparation to ensure adequate recovery of radiolabelled sample, metabolites and internal standard. b) The instrument background count rate, when no sample or radiolabel is present in the flow cell, is a function of shielding and a reduction in noise obtained with a coincidence time below one microsecond. c) The minimum detectable amount of label depends upon the machine background, HPLC eluent and scintillator flow, whether or not packed flow cells are used, flow cell geometry, and the scintillator used. d) Three types of flow cell have been designed to cover the majority of HPLC and isotope applications. e) The performance of solid and liquid scintillators. It is shown that an instrument has been designed taking account of these parameters. The resulting design satisfies present high sensitivity counting requirements and maintains the resolution of current HPLC procedures when detection is by simultaneous flow radioassay and by optical methods.

Key Words

Post-column monitoring Radioactivity monitor Low-level counting Liquid scintillator Flow cells 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    M. J. Ewer, N. G. L. Harding, Micellular Scintillators. Chap. 19 in Liquid Scintillation Counting, vol. 3, Eds.M. A. Crook, P. Johnston, Pub. Heyden & Co, London, 1974.Google Scholar
  2. [2]
    E. T. McGuiness, M. L. Cullen, J. Chem. Ed.47, A9 (1970).Google Scholar
  3. [3]
    G. B. Siewerda, H. Poppe, J. F. K. Huber, Anal. Chim. Acta78, 343 (1975).CrossRefGoogle Scholar
  4. [4]
    P. I. Adriaenssens, L. F. Prescott, J. Pharm. Pharmac.6, 87–88 (1978).Google Scholar
  5. [5]
    T. Buchanan, P. Adriaenssens, M. J. Stewart, Clin. Chim Acta99(2), 161–167 (1979).CrossRefPubMedGoogle Scholar
  6. [6]
    S. H. Curry, R. Shelpton, In blood, drugs and other analytical challenges, Ed.E. Reid, Pub. Ellis Horwood, London, pp 29–42, 1978.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1982

Authors and Affiliations

  • N. G. L. Harding
    • 1
  • Y. Farid
    • 1
  • M. J. Stewart
    • 1
  • J. Shepherd
    • 2
  • D. Nicoll
    • 2
  1. 1.Department of Pathological BiochemistryRoyal InfirmaryGlasgowUK
  2. 2.Nuclear Enterprises LimitedEdinburghUK

Personalised recommendations